Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,783 | 744 | 99.8% |
| Education | $28.75 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,485 | 95 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,110 | 58 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,004 | 60 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $837.75 | 50 | $0 (2024) |
| Novo Nordisk Inc | $814.32 | 63 | $0 (2024) |
| PFIZER INC. | $790.65 | 65 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $709.12 | 39 | $0 (2024) |
| ABBVIE INC. | $534.55 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $462.44 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $440.55 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,292 | 65 | IRONWOOD PHARMACEUTICALS, INC ($205.22) |
| 2023 | $986.31 | 52 | Ironwood Pharmaceuticals, Inc ($221.11) |
| 2022 | $1,454 | 84 | Ironwood Pharmaceuticals, Inc ($200.97) |
| 2021 | $2,417 | 134 | Amgen Inc. ($278.64) |
| 2020 | $1,381 | 88 | Amgen Inc. ($277.20) |
| 2019 | $1,965 | 99 | Teva Pharmaceuticals USA, Inc. ($525.30) |
| 2018 | $1,210 | 96 | Amgen Inc. ($208.70) |
| 2017 | $2,107 | 131 | Janssen Pharmaceuticals, Inc ($521.80) |
All Payment Transactions
749 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 12/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.28 | General |
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.49 | General |
| 11/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: GI | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: LIVER DISEASE | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Rare Disease | ||||||
| 11/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 10/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: LIVER DISEASE | ||||||
| 10/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Rare Disease | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.42 | General |
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Bone Health | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: LIVER DISEASE | ||||||
| 09/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: LIVER DISEASE | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Oncology | ||||||
| 08/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.75 | General |
| Category: GI | ||||||
| 08/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,617 | 2,609 | $290,228 | $125,382 |
| 2022 | 32 | 2,048 | 3,518 | $399,260 | $173,625 |
| 2021 | 32 | 2,620 | 4,146 | $424,761 | $220,421 |
| 2020 | 37 | 3,028 | 4,572 | $428,408 | $197,203 |
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 290 | 654 | $81,444 | $36,849 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 456 | $97,877 | $35,094 | 35.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 207 | 207 | $33,518 | $23,491 | 70.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 36 | 42 | $11,070 | $6,080 | 54.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 86 | 127 | $10,707 | $4,545 | 42.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 130 | 159 | $8,159 | $3,234 | 39.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $5,720 | $2,784 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,376 | $1,754 | 40.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 70 | 181 | $6,335 | $1,725 | 27.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 25 | $1,625 | $1,593 | 98.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,000 | $1,514 | 25.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 151 | 167 | $7,930 | $1,446 | 18.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 41 | $1,293 | $1,222 | 94.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 25 | 29 | $2,057 | $1,168 | 56.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 21 | 21 | $2,076 | $799.26 | 38.5% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 18 | 18 | $1,530 | $615.00 | 40.2% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 12 | $1,200 | $450.84 | 37.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 22 | 22 | $2,398 | $247.20 | 10.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 29 | $290.00 | $243.60 | 84.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 34 | 39 | $750.00 | $219.38 | 29.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 18 | 35 | $335.00 | $112.35 | 33.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 41 | 200 | $2,944 | $76.70 | 2.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 29 | 80 | $384.00 | $71.56 | 18.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 14 | $210.00 | $47.74 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 344 | 671 | $142,550 | $54,262 | 38.1% |
About Dr. Musib Gappy, MD
Dr. Musib Gappy, MD is a Internal Medicine healthcare provider based in Hazel Park, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477544088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Musib Gappy, MD has received a total of $12,812 in payments from pharmaceutical and medical device companies, with $1,292 received in 2024. These payments were reported across 749 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($12,783).
As a Medicare-enrolled provider, Gappy has provided services to 9,313 Medicare beneficiaries, totaling 14,845 services with total Medicare billing of $716,631. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hazel Park, MI
- Active Since 11/02/2005
- Last Updated 02/17/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477544088
Products in Payments
- Linzess (Drug) $698.53
- EVENITY (Biological) $626.41
- AJOVY (Drug) $532.27
- INVOKANA (Drug) $506.35
- XARELTO (Drug) $491.33
- Ozempic (Drug) $392.82
- FARXIGA (Drug) $385.30
- Vascepa (Drug) $374.63
- JARDIANCE (Drug) $320.90
- Prolia (Biological) $318.98
- TRELEGY ELLIPTA (Drug) $301.95
- AJOVY (Biological) $299.93
- CHANTIX (Drug) $290.02
- AUSTEDO (Drug) $250.72
- XIFAXAN (Drug) $234.56
- Aimovig (Biological) $225.87
- ZENPEP (Drug) $211.67
- Rybelsus (Drug) $203.30
- Repatha (Biological) $200.98
- EMGALITY (Drug) $197.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hazel Park
Dr. Iyad Alosachie, M.d, M.D
Internal Medicine — Payments: $23,790
Dr. Jawad Agha, Md, MD
Internal Medicine — Payments: $2,081
Kiranmayi Surapaneni, Md, MD
Internal Medicine — Payments: $1,222
Dr. Shawn Gappy, M.d, M.D
Internal Medicine — Payments: $676.08
Lubna Sarraf, M.d, M.D
Internal Medicine — Payments: $300.90
Dr. Mohammed Haq, M.d, M.D
Internal Medicine — Payments: $51.03